FDA clears COVID-19 vaccines for children under 5
source link: https://finance.yahoo.com/news/fda-clears-covid-19-vaccines-131916253.html
Go to the source link to view the article. You can view the picture content, updated content and better typesetting reading experience. If the link is broken, please click the button below to view the snapshot at that time.
FDA clears COVID-19 vaccines for children under 5
S&P 500
3,679.24+12.47(+0.34%)Dow 30
29,939.96+12.89(+0.04%)Nasdaq
10,805.22+159.12(+1.49%)Russell 2000
1,669.95+20.11(+1.22%)Crude Oil
110.15-7.44(-6.33%)- 1,839.60-10.30(-0.56%)
Silver
21.60-0.28(-1.30%)EUR/USD
1.0493-0.0059(-0.5553%)10-Yr Bond
3.2390-0.0680(-2.06%)GBP/USD
1.2213-0.0138(-1.1181%)USD/JPY
134.9780+2.7380(+2.07%)BTC-USD
20,519.70-387.25(-1.85%)CMC Crypto 200
434.87+1.93(+0.45%)FTSE 100
7,016.25-28.73(-0.41%)Nikkei 225
25,963.00-468.20(-1.77%)
FDA clears COVID-19 vaccines for children under 5
The U.S. Food and Drug Administration has authorized use of the COVID-19 vaccines from Pfizer and BioNTech, and from Moderna, for kids between six months and five years of age. The FDA's decision follows a lengthy review process, and the dosage for children under five is greatly reduced relative to those for older children and adults.
While Pfizer's vaccine was previously authorized in the U.S. for people five and up, Moderna's inoculation was limited to those aged 18 or above. The new authorization clears use of Moderna for children aged six months to 17 years.
This isn't the final step before inoculation programs begin for the new age groups: The Centers for Disease Control will offer additional guidance and a recommendation, which is a step not strictly required, but usually followed, by doctors and pharmacists who perform the inoculations. Still, vaccinations for those under five in the U.S. could begin rolling out as soon as Monday.
The FDA's decision is based on tests of more than 4,526 volunteer participants, while Moderna's is based on a study involving over 6,300 children.
Investor's Business DailyIs Moderna Stock A Buy As The Covid Battle With Pfizer Heats Up?
Is Moderna stock a buy after the FDA authorized its Covid vaccine for children as young as 6 months old? Is MRNA stock a buy right now?
21m ago
This Juneteenth, Black America Has an Important Opportunity to Increase Its Global Impact
There is a great opportunity for allyship this June 19
1d ago
LA TimesFDA authorizes 1st COVID-19 shots for infants, preschoolers
U.S. youngsters under 5 will be eligible for the shots as soon as next week, about 1 1/2 years after the vaccines first became available in the U.S. for adults.
7h ago
The HillFDA signs off on COVID vaccines for kids age 5 and younger
The Food and Drug Administration (FDA) on Friday gave the green light to COVID-19 vaccines for children ages 5 and younger, a key step toward making the shots available for the youngest children. The agency authorized the vaccine from Pfizer and BioNTech for kids ages 6 months to 4 years old, as well as a…
7h ago
The Daily RecordCelebrate Juneteenth & Father's Day while recognizing that racism in America still exists
On Juneteenth and Father’s Day, how can we celebrate freedom when our Black neighbors are mistreated, or fathers when Black men are seen as suspects?
7h ago
The IndependentBiden celebrates ‘huge relief’ for parents as FDA authorises Covid vaccine for young kids
‘Today is a day of huge relief for parents and families across America,’ Biden says
3h ago
Yahoo FinancePfizer, Moderna COVID-19 vaccines recommended for kids 5 and younger
FDA's advisory committee checked the first of four boxes that would allow COVID-19 vaccines for kids 5 and under to be authorized in the U.S. Wednesday.
2d ago
QuartzEverything you need to know about covid-19 vaccines for kids under 5
Today (June 15), a US Food and Drug Administration (FDA) panel for the first time endorsed a covid-19 vaccine for children under five years old; emergency use authorization (EUA), which would make the vaccines available, is expected to follow as early as Friday (we will update this article if/when that happens). The endorsement comes after the FDA panel reviewed the clinical trial data for vaccines made by Moderna and Pfizer-BioNTech.
1d ago
Yahoo News VideoFDA approves Pfizer, Moderna vaccines for young children
The commissioner of the Food and Drug Administration, Dr. Robert Califf, spoke at a virtual press conference after the agency approved the emergency use authorization for the Moderna and the Pfizer-BioNTech COVID-19 vaccines for children as young as 6 months old.
4h ago
Fort Worth Star-TelegramNot even 2nd Amendment rights are absolute. Let’s talk about keeping guns from the insane
Fellow conservatives, not every idea on guns is a slippery slope to confiscation. [Opinion]
9h ago
ReutersAnalysis-Air fares and staff gaps cast a shadow on transatlantic travel rebound
MONTREAL/CHICAGO (Reuters) -Airlines expect the end of COVID testing requirements in North America to accelerate a rebound in transatlantic traffic - but soaring fares due to surging fuel costs and staffing shortages may slam the brakes on rising demand in the world's largest international travel market. A U.S. requirement that arriving air travelers test negative for COVID-19 had been blamed by carriers for dampening demand. But a week after the White House scrapped the rule, airlines are reporting a surge of interest in international travel.
1d ago
ReutersUPDATE 6-U.S. FDA opens way to COVID vaccines for kids under 5, CDC up next
The U.S. Food and Drug Administration on Friday authorized two COVID-19 vaccines for children under 5, opening the door to vaccinating millions of the country's youngest children once the Centers for Disease Control and Prevention agrees. The FDA authorized Pfizer-BioNTech's COVID-19 vaccine for children aged 6 months to 4 years and Moderna Inc's shot for those 6 months to 17 years. Pfizer's is already authorized for those over the age of 5.
7h ago
Raleigh News and ObserverCOVID-19 vaccine appointments for children under 5 in NC will likely open next week
The Moderna and Pfizer vaccines were authorized by the FDA for children between the ages of six months and 5 years on Friday.
3h ago
FDA advisors vote to recommend vaccines for preschoolers, toddlers and babies
Advisors with The Food and Drug Administration voted Wednesday to recommend authorizing both Moderna and Pfizer’s Covid-19 vaccines to help protect the youngest children.
2d ago
Barrons.comFDA Authorizes Covid-19 Vaccines for Young Children, Setting Stage for Call by CDC
The Food and Drug Administration decision came shortly before a widely anticipated meeting of advisers to the Centers for Disease Control and Prevention.
6h ago
TheStreet.comThe Fed's Hands Are Tied While It Watches the Dominos Fall
After decades of printing more and more money to tape up the economy like an old car in need of an overhaul, the Fed now sees its policies coming back to bite.
1d ago
BloombergChina’s Zero-Covid Policy to Stay Into 2023, US Envoy Says
(Bloomberg) -- China’s stringent “zero Covid” policy of travel restrictions and city-wide lockdowns is likely to stretch into next year, and is actively discouraging American and European investment in China, the US ambassador to the country said.Most Read from BloombergChina Says It May Have Detected Signals From Alien CivilizationsMusk, Tesla, SpaceX Are Sued for Alleged Dogecoin Pyramid Scheme'Drip Pricing' Is Turning Checkout Into a Nasty SurpriseTech Leads Gains as Traders Parse Fed’s Promi
1d ago
The Wall Street JournalInflation-Weary Consumers Shift Shopping Habits, Kroger Says
The Cincinnati-based grocery chain says its margin fell, as the company aimed to offer more deals to inflation-battered shoppers and navigated higher supply-chain costs.
1d ago
US envoy sees China lockdowns extending into 2023
China is likely to keep imposing sweeping lockdowns into 2023, the US ambassador said Thursday, as he cautioned that the zero-Covid strategy was hurting business.
1d ago
Investor's Business Daily5 Best Chinese Stocks: Two Tesla Rivals Setting Up
Hundreds of Chinese companies are listed on U.S. markets. But which are the best Chinese stocks to buy or watch right now? Among the best are JD.com, NetEase, Li Auto, Xpeng and BYD Co.. China is the world's most-populous nation and the second-largest economy, with a booming urban middle class and amazing entrepreneurial activity.
9h ago- Yahoo News Video
A day after testing positive for COVID, Fauci testifies remotely before Senate committee
One day after testing positive for COVID-19, Dr. Anthony Fauci testified remotely at a hearing of the Senate Committee on Health, Education, Labor and Pensions to update lawmakers on the federal response to the coronavirus pandemic.
1d ago - Reuters
Omicron less likely to cause long COVID - UK study
The Omicron variant of coronavirus is less likely to cause long COVID than previous variants, according to the first peer-reviewed study of its kind from the United Kingdom. Researchers at King's College London, using data from the ZOE COVID Symptom study app, found the odds of developing long COVID after infection were 20% to 50% lower during the Omicron wave in the UK compared to Delta. Long COVID, which includes prolonged symptoms ranging from fatigue to 'brain fog', can be debilitating and continue for weeks or months.
21h ago - MarketWatch
Acadia Pharmaceuticals stock halted for FDA panel to review treatment for hallucinations stemming from Alzheimer's disease psychosis
Acadia Pharmaceuticals Inc. said Friday its stock will be halted from trading Friday as a U.S. Food and Drug Administration panel meets virtually to discuss a new drug application for a treatment for hallucinations and delusions associated with Alzheimer's disease psychosis. The FDA's Psychopharmacologic Drugs Advisory Committee will review Acadia's Nuplazid at a meeting scheduled for 8:45 a.m. Eastern. About six million people living in the U.S. have Alzheimer's disease, according to the Alzhei
9h ago - Benzinga
Why Scholar Rock Shares Are Trading Higher Today
Scholar Rock Holding Corp (NASDAQ: SRRK) announced new data from the Phase 2 TOPAZ trial extension period evaluating apitegromab in non-ambulatory patients with Types 2 and 3 Spinal Muscular Atrophy (SMA) receiving an SMN therapy. The trial assessed patient outcomes after 24 months of treatment. All 35 non-ambulatory patients (Cohorts 2 and 3) and 12 of 23 ambulatory patients (Cohort 1) were receiving Biogen Inc's (NASDAQ: BIIB) Spinraza (nusinersen) maintenance therapy. Related: Scholar Rock Sh
4h ago - Barrons.com
The Days of Big Pharma Are Over. What the Era of Big Biotech Means for Investors.
When GSK spins off its consumer health division in July, it will become one of the last drug conglomerates to shed its sideline businesses to focus on biotech-style medicines. The shift has big implications for investors—and overall public health.
47m ago - Yahoo Finance
Senator cites Elon Musk in urging agency heads to end remote work
Senators pressed for ending the public health emergency and for more return to office at federal agencies during a Senate committee Thursday.
1d ago - American City Business Journals
Fastest-growing public companies: Revenue spikes for Waltham cancer drug firm
Syndax Pharmaceuticals has toiled for years toward finding cancer therapies that can improve the lives of patients.
11h ago - CNW Group
Trulieve Opening New Port Richey, FL Medical Marijuana Dispensary
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, today announced the opening of a new medical dispensary in New Port Richey, Fla. Located at 5422 US Hwy 19, the doors will open at 9 a.m. on Thursday, June 16, 2022.
1d ago - MarketWatch
FDA clears path for CDC to authorize mRNA vaccines in youngest children, but Florida officials say they do not recommend them
The Food and Drug Administration took the advice of a panel of advisers and authorized the COVID-19 vaccines developed by BioNTech and Pfizer and Moderna for children as young as six months old on Friday, adding the final group to the nation's vaccine program.
2h ago - Barrons.com
Roche’s Failed Alzheimer’s Trial Could Have Implications for Lilly, Biogen
Roche's trial aimed at preventing Alzheimer’s disease had failed. That's a bad sign for Biogen and Eli Lilly, which are pushing forward with similar drugs.
1d ago - The Hill
Clyburn hits DeSantis: Reverse or explain ‘inexplicable’ decision over child COVID-19 vaccines
House Majority Whip James Clyburn (D-S.C.) demanded that Florida Gov. Ron DeSantis (R) reverse or explain his decision after he declined to order COVID-19 vaccines for children under 5 years of age. In a letter sent Friday, Clyburn, the chairman of the the House Select Subcommittee on the Coronavirus Crisis, added that he was concerned by DeSantis’s public…
3h ago - Benzinga
HC Wainwright Sees Opportunity For Acadia's Alzheimer's Candidate
HC Wainwright says FDA's briefing document on ACADIA Pharmaceuticals Inc's (NASDAQ: ACAD) pimavanserin was not unexpected. It reiterates the stock with a Buy rating and a price target of $36.00. Related: Why ACADIA Pharmaceuticals Shares Are Trading Higher Today? The analysts believe the below points are left open for discussion when the AdCom members meet tomorrow: The closeness between Parkinson's disease dementia (PDD) and Alzheimer's disease dementia (ADD) in terms of disease mechanism argue
1d ago - American City Business Journals
The Petri Dish: Amylyx, Alnylam net drug approvals
The Massachusetts life sciences industry is rife with companies developing drugs and devices to tackle serious diseases, inking new partnership deals, raising money, expanding facilities and more. Here's The Petri Dish, a roundup of news that may get overlooked amid the influx of health care happenings. Canada approves Amylyx drug Amylyx Pharmaceuticals Inc. (Nasdaq: AMLX) scored its first-ever approval from Health Canada for its amyotrophic lateral sclerosis (ALS) drug Albrioza.
1d ago - SheKnows
The Mobobaby Feeding Hat is a Nursing Game-Changer
In today’s edition of “products so brilliantly simple we can’t believe no one ever thought of it before,” we present to you the genius Mobobaby Feeding Hat + Nursing Cover. It’s a lightweight way to provide some privacy while nursing in public that doesn’t involve a blanket over anybody’s head, and it’s going to be […]
1d ago - Yahoo News UK
'The BA.4/5 wave is here': COVID infections soar in England by more than 300k in a week
It follows experts’ warnings this week that a new wave of COVID is 'kicking off' in England.
9h ago - Reuters
EU drugs watchdog begins review of Moderna's variant COVID vaccine
LONDON (Reuters) -The European Medicines Agency (EMA) started a rolling review on Friday of a variant-adapted COVID-19 vaccine from Moderna, as coronavirus cases linked to Omicron sub-variants see an uptick in the region. U.S.-based Moderna's so-called bivalent vaccine targets two strains of the SARS-CoV-2 virus behind COVID, the original strain first identified in China, and the Omicron variant. Last week, Moderna said its bivalent vaccine produced a better immune response against Omicron than the original shot.
5h ago - TheStreet.com
Microsoft-Developed Covid Tech Can Now Detect Lyme Disease
Adaptive Biotech's T-Detect Lyme was created by combining Azure cloud computing and sequencing of the immune system.
1d ago - Washington Post
Congressional covid funding deal appears doomed after GOP criticism
A congressional deal for billions of dollars in additional coronavirus funding appeared all but dead Thursday after Senate Republicans accused the White House of being dishonest about the nation's pandemic funding needs. Sen. Mitt Romney, R-Utah, who brought the Senate to the brink of a bipartisan $10 billion coronavirus funding deal in March, said the Biden administration had provided "patently false" information about its inability to buy additional vaccines, treatments and supplies. He cited
21h ago - The Week
Biden issues executive order cracking down on 'discredited and dangerous' conversion therapy
Biden issues executive order cracking down on 'discredited and dangerous' conversion therapy
2d ago - Investor's Business Daily
Why Acadia Pharma Surged Despite A Negative FDA Take On Its Lead Drug
There were no surprises in the FDA's assessment of an Alzheimer's drug from Acadia Pharmaceuticals, and ACAD stock surged Wednesday.
2d ago
Recommend
About Joyk
Aggregate valuable and interesting links.
Joyk means Joy of geeK